CRL

#3612
Charles River Laboratories International, Inc. Common Stock
1.8 1 USD
-99.00%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.81
1.84
Range Annuel
1.60
228.88
Changement quotidien
-99.00%
Changement Mensuel
-98.90%
Evolution sur 6 mois
-98.98%
Changement Annuel
-99.08%
Clôture Précédente
181.4 1
Open
1.8 3
Low
1.8 1
High
1.8 4
Volume
662
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Charles River Laboratories International, Inc. Common Stock

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.

Nouvelles